Hepatic encephalopathy (HE) is a serious complication of cirrhosis that contributes to cognitive decline, frequent hospitalizations, and care challenges post-discharge. This 60-minute MOC Section 1–accredited webinar delivers practical, evidence-based strategies to improve HE management in hospitalized patients—from timely diagnosis and treatment with lactulose and rifaximin to optimizing discharge planning with standardized order sets and patient support programs (PSPs). Through real-world scenarios and clinical best practices, participants will learn how to streamline care, reduce recurrences, and improve outcomes across transitions.
This program has received financial support from Lupin Pharma Canada in the form of an unrestricted educational grant.
